Login
You're viewing the mstdn.social public feed.
  • sport of sacred spherical cowsbeadsland@beige.party
    Jul 6, 2026, 7:01 AM

    The Labor Bureau's 'Current Population Survey (Household Survey)' saw a nearly 1.14 million increase between the end of the recession in 2008 and the beginning of the pandemic in 2020. This amounting to an average increase in the disabled population of less than 94 thousand a year.

    For the period from April 2020 to date, that figure has climbed nearly 1.24 million, for an average increase in the disabled population of over 200 thousand a year, with no sign of slowing. Disability has climbed faster in the past half dozen years than it had in the previous dozen.

    Another way to say all of this is that disability has been increasing at twice the pre-pandemic rate for six years straight, and continues to do so as we enter the pandemic's seventh year.

    #CovidIsNotOver #LongCovid #covid #covid19 #CountLongCovid

    Chart: Population - With a Disability, 16 Years and over Source: U.S. Bureau of Labor Statistics via FRED® Line chart showing monthly disability statistics from June 2008 to June 2026. Two grey regions reflect recessions ending in mid-2009 and again for two months of 2020. A flyover indicates that in February 2020, disability count was just shy of 31 million persons. Coming out of 2008 recession, that count was around 27 million, dropping to 26 million in 2010, before trending jaggedly upward thereafter, though seeming to level off from 2016 onward, the 31 million mark approached in early 2020 matching a similar peak on March 2019, with two peaks over 30.5 million in early and late 2017. A comparable pattern in seen in 2020, with the count dropping below 29 million, before climbing, much more steeply, to now nearly 37 million. Importantly, this trendline does not replicate the leveling off seen in 2016-2019.
    💬 1🔄 21⭐ 11

Replies

  • sport of sacred spherical cowsbeadsland@beige.party
    Jul 7, 2026, 6:31 AM

    Most recent #CDC dataset, updated Monday, again omits Nowcast for the most recent four-week period, "[d]ue to low numbers of sequences being reported to CDC".

    For May-June reporting, XFG.23.1.3 / RV family appears to gain share among Stratus XFG family. Stratus-Eleventy XFG.1.1, now appears to be in retreat. Overall, XFG fam, the sole representative of the FDA-Vaccine-Target LP.8.1 lineage, continue to hold about two thirds share.

    Nimbus NB.1.8.2 / PQ family appears to lose ground, as LF.7 family holds firm, under pressure from Cicada BA.3.2, and a troubling "Other" category that has exploded into prominence in the latest round of reporting.

    Note that, in absence of robust data from states, CDC has given up modeling historical estimates, instead giving only "empiric" shares of reported sequences.

    Raj's dashboard, updated end of March, showed XFG.1.1 at a quarter share, for the last half of the most recent reporting period, while Cicada grandkid RE.2 made a significant appearance.

    That said, said GISAID data was dominated by paltry submissions from New York (171), Minnesota (85), Maryland (84), Nebraska (53), and Arizona (17).

    ❖ #ThisIsOurPolio #variants #CovidIsNotOver #dataviz #datavis

    Chart: Est. & Reported U.S. Covid Variant Proportions by Common Name Sources: CDC, Cov-Lineages, NYITCOM, others [ beadsland on Ko-fi ] Reskin of CDC's Variants Nowcast, and any significant variants in GISAID not broken out by CDC. Four bar-style tree-charts, for four-week periods through 5/10–6/6. Legend of last four-week period, organized by subheadings of color-grouped families and convergent clusters. Percentages overlay each color key, reflecting share as of most recent tree-chart. Over nine tenths Omicron B.1.1.529 / BA dynasty. LP.8.1.2 / NW family accounts for over two thirds share; Stratus-Eleventy XFG.1.1 for over a quarter. For 2/15–3/14, packed bubble charts fill single-variant tiles, reflecting GISAID detail not shown by CDC's Nowcast. Legend: FDA-Vaccine-Target [purples]: 29% - XFG.1.1.1 / RP† & other Stratus-Eleventy XFG.1.1 8% - XFG.14.1, XFG.2.5.1 & XFG.14.1.1† 8% - XFG.6 1% - XFG.10.4 7% - XFV & other Stratus XFG 0% - other FDA-Vaccine-Target LP.8.1 XFG.23.1.3 [reds]: 6% - RV.1 9% - other XFG.23.1.3 / RV Omicron-2 BA.2 [green]: 12% - PQ.2.8.1 / RC, PQ.17 & Nimbus NB.1.8.1 / PQ Cicada [brown]: 8% - RE.2† & other Cicada BA.3.2 WHO-Vaccine-Target JN.1 [blue]: 6% - LF.7.9, XFZ & LF.7 Other [grey]: 6% - Other (not specified) _____ Cicada BA.3.2 is a child of 2023 Omicron-3 BA.3. XFV is a child of Spring 2025's FDA-Vaccine-Target LP.8.1 and left-field Stratus scion XFG.3.3.1 / SE. [Some footnotes omitted, due to too many recombinants.]
    💬 0🔄 1⭐ 0